Table of Contents

February 2011, Volume 18, Number 1

Editorials

Commentary

    • Debbie L Hay,
    • Christopher S Walker,
    • and David R Poyner

    Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges

    Endocr Relat Cancer 18 (1) C1-C14, doi:10.1677/ERC-10-0244 first published on 4 November 2010

Review

    • Leigh C Murphy,
    • Srinivas V Seekallu,
    • and Peter H Watson

    Clinical significance of estrogen receptor phosphorylation

    Endocr Relat Cancer 18 (1) R1-R14, doi:10.1677/ERC-10-0070 first published on 13 December 2010

Regular papers

    • Donata Vitagliano,
    • Valentina De Falco,
    • Anna Tamburrino,
    • Sabrina Coluzzi,
    • Giancarlo Troncone,
    • Gennaro Chiappetta,
    • Fortunato Ciardiello,
    • Giampaolo Tortora,
    • James A Fagin,
    • Anderson J Ryan,
    • Francesca Carlomagno,
    • and Massimo Santoro

    The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells

    Endocr Relat Cancer 18 (1) 1-11, doi:10.1677/ERC-09-0292 first published on 13 October 2010
    • Yan Huang,
    • Hongyan Jin,
    • Yingtao Liu,
    • Jiayi Zhou,
    • Jingxin Ding,
    • Kwai Wa Cheng,
    • Yinhua Yu,
    • and Youji Feng

    FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5

    Endocr Relat Cancer 18 (1) 13-26, doi:10.1677/ERC-09-0308 first published on 13 October 2010
    • Yu-Yu Liu,
    • Michael P Brandt,
    • Daniel H Shen,
    • Richard T Kloos,
    • Xiaoli Zhang,
    • and Sissy M Jhiang

    Single photon emission computed tomography imaging for temporal dynamics of thyroidal and salivary radionuclide accumulation in 17-allyamino-17-demothoxygeldanamycin-treated thyroid cancer mouse model

    Endocr Relat Cancer 18 (1) 27-37, doi:10.1677/ERC-10-0185 first published on 13 October 2010
    • Nandini V L Hayes,
    • Edith Blackburn,
    • Mary M Boyle,
    • Graham A Russell,
    • Teresa M Frost,
    • Byron J T Morgan,
    • and William J Gullick

    Expression of neuregulin 4 splice variants in normal human tissues and prostate cancer and their effects on cell motility

    Endocr Relat Cancer 18 (1) 39-49, doi:10.1677/ERC-10-0112 first published on 19 October 2010
    • O Hentic,
    • A Couvelard,
    • V Rebours,
    • M Zappa,
    • S Dokmak,
    • P Hammel,
    • F Maire,
    • D O'Toole,
    • P Lévy,
    • A Sauvanet,
    • and P Ruszniewski

    Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas

    Endocr Relat Cancer 18 (1) 51-59, doi:10.1677/ERC-09-0319 first published on 19 October 2010
    • Gregory A Kaltsas,
    • Janet L Cunningham,
    • Sture E Falkmer,
    • Lars Grimelius,
    • and Apostolos V Tsolakis

    Expression of connective tissue growth factor and IGF1 in normal and neoplastic gastrointestinal neuroendocrine cells and their clinico-pathological significance

    Endocr Relat Cancer 18 (1) 61-71, doi:10.1677/ERC-10-0026 first published on 19 October 2010
    • Dewi Astuti,
    • Christopher J Ricketts,
    • Rasheduzzaman Chowdhury,
    • Michael A McDonough,
    • Dean Gentle,
    • Gail Kirby,
    • Susanne Schlisio,
    • Rajappa S Kenchappa,
    • Bruce D Carter,
    • William G Kaelin, Jr,
    • Peter J Ratcliffe,
    • Christopher J Schofield,
    • Farida Latif,
    • and Eamonn R Maher

    Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility

    Endocr Relat Cancer 18 (1) 73-83, doi:10.1677/ERC-10-0113 first published on 19 October 2010
    OPEN ACCESS ARTICLE
    • Susanna Leskelä,
    • Luis J Leandro-García,
    • Marta Mendiola,
    • Jorge Barriuso,
    • Lucía Inglada-Pérez,
    • Iván Muñoz,
    • Beatriz Martínez-Delgado,
    • Andrés Redondo,
    • Javier de Santiago,
    • Mercedes Robledo,
    • David Hardisson,
    • and Cristina Rodríguez-Antona

    The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients

    Endocr Relat Cancer 18 (1) 85-95, doi:10.1677/ERC-10-0148 first published on 4 November 2010
    • Graeme Eisenhofer,
    • Karel Pacak,
    • Thanh-Truc Huynh,
    • Nan Qin,
    • Gennady Bratslavsky,
    • W Marston Linehan,
    • Massimo Mannelli,
    • Peter Friberg,
    • Stefan K Grebe,
    • Henri J Timmers,
    • Stefan R Bornstein,
    • and Jacques W M Lenders

    Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma

    Endocr Relat Cancer 18 (1) 97-111, doi:10.1677/ERC-10-0211 first published on 4 November 2010
    • Sudipan Karmakar,
    • Estrella A Foster,
    • Julia K Blackmore,
    • and Carolyn L Smith

    Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line

    Endocr Relat Cancer 18 (1) 113-127, doi:10.1677/ERC-09-0285 first published on 8 November 2010
    • Silvana Libertini,
    • Antonella Abagnale,
    • Carmela Passaro,
    • Ginevra Botta,
    • Sara Barbato,
    • Paolo Chieffi,
    • and Giuseppe Portella

    AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947

    Endocr Relat Cancer 18 (1) 129-141, doi:10.1677/ERC-10-0234 first published on 11 November 2010
    • Lucia Martiniova,
    • Shiromi M Perera,
    • Frederieke M Brouwers,
    • Salvatore Alesci,
    • Mones Abu-Asab,
    • Amanda F Marvelle,
    • Dale O Kiesewetter,
    • David Thomasson,
    • John C Morris,
    • Richard Kvetnansky,
    • Arthur S Tischler,
    • James C Reynolds,
    • Antonio Tito Fojo,
    • and Karel Pacak

    Increased uptake of [123I]meta-iodobenzylguanidine, [18F]fluorodopamine, and [3H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors

    Endocr Relat Cancer 18 (1) 143-157, doi:10.1677/ERC-10-0090 first published on 22 November 2010
    • D Deandreis,
    • A Al Ghuzlan,
    • S Leboulleux,
    • L Lacroix,
    • J P Garsi,
    • M Talbot,
    • J Lumbroso,
    • E Baudin,
    • B Caillou,
    • J M Bidart,
    • and M Schlumberger

    Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?

    Endocr Relat Cancer 18 (1) 159-169, doi:10.1677/ERC-10-0233 first published on 30 November 2010
    • Kyle M Walsh,
    • Murim Choi,
    • Kjell Oberg,
    • Matthew H Kulke,
    • James C Yao,
    • Chengqing Wu,
    • Magdalena Jurkiewicz,
    • Ling-I Hsu,
    • Susanne M Hooshmand,
    • Manal Hassan,
    • Eva T Janson,
    • Janet L Cunningham,
    • Evan Vosburgh,
    • Richard S Sackler,
    • Richard P Lifton,
    • Andrew T DeWan,
    • and Josephine Hoh

    A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum

    Endocr Relat Cancer 18 (1) 171-180, doi:10.1677/ERC-10-0248 first published on 7 December 2010
    • Atsuko Kasajima,
    • Marianne Pavel,
    • Silvia Darb-Esfahani,
    • Aurelia Noske,
    • Albrecht Stenzinger,
    • Hironobu Sasano,
    • Manfred Dietel,
    • Carsten Denkert,
    • Christoph Röcken,
    • Bertram Wiedenmann,
    • and Wilko Weichert

    mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours

    Endocr Relat Cancer 18 (1) 181-192, doi:10.1677/ERC-10-0126 first published on 15 December 2010
    • Catherine Ory,
    • Nicolas Ugolin,
    • Céline Levalois,
    • Ludovic Lacroix,
    • Bernard Caillou,
    • Jean-Michel Bidart,
    • Martin Schlumberger,
    • Ibrahima Diallo,
    • Florent de Vathaire,
    • Paul Hofman,
    • José Santini,
    • Bernard Malfoy,
    • and Sylvie Chevillard

    Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors

    Endocr Relat Cancer 18 (1) 193-206, doi:10.1677/ERC-10-0205 first published on 9 December 2010
    OPEN ACCESS ARTICLE
|

This Issue

February 2011; 18 (1)
Cover
  1. Editorials
  2. Commentary
  3. Review
  4. Regular papers

Find articles in this issue containing these words:

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most